In the medical marijuana space, when licensed producers get together to talk about who has the highest quality product, Abcann Medicinals (which will go public in the PDA.H shell) is never outside the conversation.
With a thriving wholesale business supplying other LPs now switching to a patient building program and keeping the good stuff for themselves, new CEO Aaron Keay brings the company deep financial markets knowledge just in time for its big shift to a public company.
When’s that shift happening? Next week, says Keay.
There’s a whole lot more in this wide ranging 45 minute chat, which took place live on our Twitch stream Tuesday, with questions asked by our online chat viewers.
Get the lowdown on this new entrant into the high level LP space on the video below (with apologies for the lack of sound in the opening minute).
— Chris Parry